| 2024-07-31 | Mr. Brent H. ZettlPresident, CEO, Secretary & Director | -470,00k | 0,00 | Verkauf | - | 33,70M | -1,38% |
| 2025-11-26 | Mr. Richard HoytIndependent Chairman | 93,56k | 0,00 | Acquisition Under Employee Benefit Plan | - | 402,56k | 30,28% |
| 2024-12-30 | John William-Richard EagleInsider | -6,40k | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-11-26 | Dr. Julie StakiwChief Medical Officer | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 150,00k | 50,00% |
| 2025-11-26 | Mr. Scott William LivingstoneVP of Clinical Research | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,46 | 150,00k | 50,00% |
| 2025-11-26 | Mr. Brent H. ZettlPresident, CEO, Secretary & Director | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,46 | 743,11k | 50,70% |
| 2025-12-01 | Dr. Charlotte Moore HepburnIndependent Director | -41,06k | 0,00 | Derivative Exercise and Sale | 0,46 | 404,29k | - |
| 2025-11-26 | Mr. Keith CarpenterChief Strategy & Investment Officer | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 521,55k | 62,20% |
| 2025-11-26 | Mr. John M. HyshkaCFO | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 200,00k | - |
| 2025-06-27 | Mr. John KnowlesIndependent Director | 74,63k | 36,61k | Kauf | 0,49 | 527,24k | 16,49% |
| 2025-06-27 | Mr. Wayne Richard BrownleeIndependent Director | 373,13k | 183,06k | Kauf | 0,49 | 4,15M | 9,87% |
| 2025-06-30 | Mr. Wayne Richard BrownleeIndependent Director | -28,18k | 0,00 | Other Derivative Disposition | 2,60 | 5,59M | -0,50% |
| 2025-06-27 | Mr. Brent H. ZettlPresident, CEO, Secretary & Director | 298,51k | 146,45k | Kauf | 0,49 | 34,91M | 0,86% |
| 2025-06-04 | Mr. Brent H. ZettlPresident, CEO, Secretary & Director | -1,21M | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |